Paracetamol Study in Patients With Low Muscle Mass

PHASE4RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 18, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
SMA IICerebral Palsy
Interventions
DRUG

Paracetamol 120Mg/5mL Oral Suspension

The subjects will be treated with paracetamol in therapeutic doses, 15mg/kg/dose every six hour, with a maximum dosage of 1 g x 4 per day, for three consecutive days.

Trial Locations (1)

2200

RECRUITING

Copenhagen Neuromuscular Center, Copenhagen

All Listed Sponsors
collaborator

Elsass Foundation

OTHER

lead

Mette Cathrine Oerngreen

OTHER